1.70
0.02 (1.49%)
| Penutupan Terdahulu | 1.68 |
| Jumlah Dagangan | 238 |
| Harga / Jualan (P/S) | 267.00 |
| Harga / Buku (P/B) | 0.660 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -173,463.83% |
| EPS Cair (TTM) | -4.34 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -94.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.00% |
| Nisbah Semasa (MRQ) | 19.49 |
| Aliran Tunai Operasi (OCF TTM) | -5.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -3.50 M |
| Pulangan Atas Aset (ROA TTM) | -43.94% |
| Pulangan Atas Ekuiti (ROE TTM) | -81.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Cardio Diagnostics Holdings Inc | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.4 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | 0.0 |
| Persekitaran Makro | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.31 |
|
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 7.55% |
| % Dimiliki oleh Institusi | 4.86% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |